Zydus’ Nesher Pharmaceuticals gets FDA nod for generic Lovaza

BY Sandra Levy

Zydus’ Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals has received the Food and Drug Administration’s blessing for Omega-3-acid ethyl esters capsules.

The product is the generic of GlaxoSmithKline’s Lovaza.

Omega-3 acid ethyl esters, a type of fat found in fish oil, is used along with diet and exercise to help lower levels of a certain blood fat, or triglyceride. It may also raise good cholesterol, or HDL.

The drug will be manufactured at Nesher’s manufacturing facility located in St. Louis, Mo.


Leave a Reply

No comments found



What area is your company focused most on in 2019?
  • Add your answer